 |
|
 |
|
|
CALGB 30901: “Randomized phase II study of maintenance pemetrexed versus observation for patients with malignant pleural mesothelioma without progression after first-line chemotherapy“
NSABP NCIC CTG MA.32F: “Biobehavioral Mechanisms of Fatigue in Patients Treated on NCIC CTG MA.32: A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer”
RTOG 0837:“A Randomized, Phase II, Double-Blind, Placebo-Controlled Trial of Conventional Chemoradiation and Adjuvant Temozolomide Plus Cediranib versus Conventional Chemoradiation and Adjuvant Temozolomide Plus Placebo in Patients with Newly Diagnosed Glioblastoma” |
|
|
 |
|
 |
|
|
|
|
|
|
|
|
Welcome to the Columbia River Oncology Program!
|
|
|
|
|
|
|
|
|
|